カテゴリー： QYResearch, 世界

世界の遺伝性血管浮腫薬市場

◆英語タイトル：Global Hereditary Angioedema Drug Market Professional Survey Report 2019
◆商品コード：DATA909X08965
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月20日（※2024年版があります。お問い合わせください）
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、遺伝性血管浮腫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、C1エステラーゼ阻害剤、カリクレイン阻害剤、選択的ブラジキニンB2受容体拮抗薬に、用途別には、小売薬局、病院薬局、オンライン薬局にセグメント区分し、遺伝性血管浮腫薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・遺伝性血管浮腫薬の世界市場概要
・遺伝性血管浮腫薬の製造コスト構成分析
・遺伝性血管浮腫薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・遺伝性血管浮腫薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・遺伝性血管浮腫薬のセグメント分析（種類別）
（C1エステラーゼ阻害剤、カリクレイン阻害剤、選択的ブラジキニンB2受容体拮抗薬）
・遺伝性血管浮腫薬のセグメント分析（用途別）
（小売薬局、病院薬局、オンライン薬局）
・遺伝性血管浮腫薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Pharming Group NV、Shire plc、CSL Limited、IBio Inc.、BioCryst Pharmaceuticals, Inc.、Ionis Pharmaceuticals, Inc.、）
・遺伝性血管浮腫薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Hereditary Angioedema Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Hereditary Angioedema Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hereditary Angioedema Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hereditary Angioedema Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hereditary Angioedema Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pharming Group NV
Shire plc
CSL Limited
IBio Inc.
BioCryst Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc.
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
C1 Esterase Inhibitor
Kallikrein Inhibitor
Selective Bradykinin B2 Receptor Antagonist

Segment by Application
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Hereditary Angioedema Drug
1.1 Definition of Hereditary Angioedema Drug
1.2 Hereditary Angioedema Drug Segment by Type
1.2.1 Global Hereditary Angioedema Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 C1 Esterase Inhibitor
1.2.3 Kallikrein Inhibitor
1.2.4 Selective Bradykinin B2 Receptor Antagonist
1.3 Hereditary Angioedema Drug Segment by Applications
1.3.1 Global Hereditary Angioedema Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Hereditary Angioedema Drug Overall Market
1.4.1 Global Hereditary Angioedema Drug Revenue (2014-2025)
1.4.2 Global Hereditary Angioedema Drug Production (2014-2025)
1.4.3 North America Hereditary Angioedema Drug Status and Prospect (2014-2025)
1.4.4 Europe Hereditary Angioedema Drug Status and Prospect (2014-2025)
1.4.5 China Hereditary Angioedema Drug Status and Prospect (2014-2025)
1.4.6 Japan Hereditary Angioedema Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Hereditary Angioedema Drug Status and Prospect (2014-2025)
1.4.8 India Hereditary Angioedema Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hereditary Angioedema Drug
2.3 Manufacturing Process Analysis of Hereditary Angioedema Drug
2.4 Industry Chain Structure of Hereditary Angioedema Drug

3 Development and Manufacturing Plants Analysis of Hereditary Angioedema Drug
3.1 Capacity and Commercial Production Date
3.2 Global Hereditary Angioedema Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hereditary Angioedema Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Hereditary Angioedema Drug Production and Capacity Analysis
4.2 Hereditary Angioedema Drug Revenue Analysis
4.3 Hereditary Angioedema Drug Price Analysis
4.4 Market Concentration Degree

5 Hereditary Angioedema Drug Regional Market Analysis
5.1 Hereditary Angioedema Drug Production by Regions
5.1.1 Global Hereditary Angioedema Drug Production by Regions
5.1.2 Global Hereditary Angioedema Drug Revenue by Regions
5.2 Hereditary Angioedema Drug Consumption by Regions
5.3 North America Hereditary Angioedema Drug Market Analysis
5.3.1 North America Hereditary Angioedema Drug Production
5.3.2 North America Hereditary Angioedema Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hereditary Angioedema Drug Import and Export
5.4 Europe Hereditary Angioedema Drug Market Analysis
5.4.1 Europe Hereditary Angioedema Drug Production
5.4.2 Europe Hereditary Angioedema Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hereditary Angioedema Drug Import and Export
5.5 China Hereditary Angioedema Drug Market Analysis
5.5.1 China Hereditary Angioedema Drug Production
5.5.2 China Hereditary Angioedema Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hereditary Angioedema Drug Import and Export
5.6 Japan Hereditary Angioedema Drug Market Analysis
5.6.1 Japan Hereditary Angioedema Drug Production
5.6.2 Japan Hereditary Angioedema Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hereditary Angioedema Drug Import and Export
5.7 Southeast Asia Hereditary Angioedema Drug Market Analysis
5.7.1 Southeast Asia Hereditary Angioedema Drug Production
5.7.2 Southeast Asia Hereditary Angioedema Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hereditary Angioedema Drug Import and Export
5.8 India Hereditary Angioedema Drug Market Analysis
5.8.1 India Hereditary Angioedema Drug Production
5.8.2 India Hereditary Angioedema Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hereditary Angioedema Drug Import and Export

6 Hereditary Angioedema Drug Segment Market Analysis (by Type)
6.1 Global Hereditary Angioedema Drug Production by Type
6.2 Global Hereditary Angioedema Drug Revenue by Type
6.3 Hereditary Angioedema Drug Price by Type

7 Hereditary Angioedema Drug Segment Market Analysis (by Application)
7.1 Global Hereditary Angioedema Drug Consumption by Application
7.2 Global Hereditary Angioedema Drug Consumption Market Share by Application (2014-2019)

8 Hereditary Angioedema Drug Major Manufacturers Analysis
8.1 Pharming Group NV
8.1.1 Pharming Group NV Hereditary Angioedema Drug Production Sites and Area Served
8.1.2 Pharming Group NV Product Introduction, Application and Specification
8.1.3 Pharming Group NV Hereditary Angioedema Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Shire plc
8.2.1 Shire plc Hereditary Angioedema Drug Production Sites and Area Served
8.2.2 Shire plc Product Introduction, Application and Specification
8.2.3 Shire plc Hereditary Angioedema Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 CSL Limited
8.3.1 CSL Limited Hereditary Angioedema Drug Production Sites and Area Served
8.3.2 CSL Limited Product Introduction, Application and Specification
8.3.3 CSL Limited Hereditary Angioedema Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 IBio Inc.
8.4.1 IBio Inc. Hereditary Angioedema Drug Production Sites and Area Served
8.4.2 IBio Inc. Product Introduction, Application and Specification
8.4.3 IBio Inc. Hereditary Angioedema Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 BioCryst Pharmaceuticals, Inc.
8.5.1 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Sites and Area Served
8.5.2 BioCryst Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Ionis Pharmaceuticals, Inc.
8.6.1 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Sites and Area Served
8.6.2 Ionis Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served

9 Development Trend of Analysis of Hereditary Angioedema Drug Market
9.1 Global Hereditary Angioedema Drug Market Trend Analysis
9.1.1 Global Hereditary Angioedema Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Hereditary Angioedema Drug Regional Market Trend
9.2.1 North America Hereditary Angioedema Drug Forecast 2019-2025
9.2.2 Europe Hereditary Angioedema Drug Forecast 2019-2025
9.2.3 China Hereditary Angioedema Drug Forecast 2019-2025
9.2.4 Japan Hereditary Angioedema Drug Forecast 2019-2025
9.2.5 Southeast Asia Hereditary Angioedema Drug Forecast 2019-2025
9.2.6 India Hereditary Angioedema Drug Forecast 2019-2025
9.3 Hereditary Angioedema Drug Market Trend (Product Type)
9.4 Hereditary Angioedema Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hereditary Angioedema Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Hereditary Angioedema Drug
Table Global Hereditary Angioedema Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Hereditary Angioedema Drug Production Market Share by Types in 2018
Figure C1 Esterase Inhibitor Product Picture
Figure Kallikrein Inhibitor Product Picture
Figure Selective Bradykinin B2 Receptor Antagonist Product Picture
Table Global Hereditary Angioedema Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Hereditary Angioedema Drug Consumption Market Share by Applications in 2018
Figure Retail Pharmacies
Figure Hospital Pharmacies
Figure Online Pharmacies
Figure Global Hereditary Angioedema Drug Revenue (Million USD) (2014-2025)
Figure Global Hereditary Angioedema Drug Production (K Pcs) (2014-2025)
Figure North America Hereditary Angioedema Drug Market Size (Million USD) (2014-2025)
Figure Europe Hereditary Angioedema Drug Market Size (Million USD) (2014-2025)
Figure China Hereditary Angioedema Drug Market Size (Million USD) (2014-2025)
Figure Japan Hereditary Angioedema Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Hereditary Angioedema Drug Market Size (Million USD) (2014-2025)
Figure India Hereditary Angioedema Drug Market Size (Million USD) (2014-2025)
Table Hereditary Angioedema Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hereditary Angioedema Drug in 2018
Figure Manufacturing Process Analysis of Hereditary Angioedema Drug
Figure Industry Chain Structure of Hereditary Angioedema Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hereditary Angioedema Drug Manufacturing Plants Distribution
Table Hereditary Angioedema Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hereditary Angioedema Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Hereditary Angioedema Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Hereditary Angioedema Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Hereditary Angioedema Drug Production Share by Manufacturers in 2018
Table Hereditary Angioedema Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Hereditary Angioedema Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Hereditary Angioedema Drug Revenue Share by Manufacturers in 2018
Table Hereditary Angioedema Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hereditary Angioedema Drug Production by Regions 2014-2019 (K Pcs)
Table Global Hereditary Angioedema Drug Production Market Share by Regions 2014-2019
Figure Global Hereditary Angioedema Drug Production Market Share by Regions in 2018
Table Global Hereditary Angioedema Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Hereditary Angioedema Drug Revenue Market Share by Regions 2014-2019
Figure Global Hereditary Angioedema Drug Revenue Market Share by Regions in 2018
Table Global Hereditary Angioedema Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Hereditary Angioedema Drug Consumption Market Share by Regions 2014-2019
Figure North America Hereditary Angioedema Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Hereditary Angioedema Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Hereditary Angioedema Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Hereditary Angioedema Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Hereditary Angioedema Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Hereditary Angioedema Drug Production, Consumption Import and Export (K Pcs)
Figure China Hereditary Angioedema Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Hereditary Angioedema Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Hereditary Angioedema Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Hereditary Angioedema Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Hereditary Angioedema Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Hereditary Angioedema Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Hereditary Angioedema Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Hereditary Angioedema Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Hereditary Angioedema Drug Production, Consumption Import and Export (K Pcs)
Figure India Hereditary Angioedema Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Hereditary Angioedema Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Hereditary Angioedema Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Hereditary Angioedema Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Hereditary Angioedema Drug Market Share by Application (2014-2019)
Table Pharming Group NV Hereditary Angioedema Drug Production Sites and Area Served
Table Pharming Group NV Hereditary Angioedema Drug Product Introduction, Application and Specification
Table Pharming Group NV Hereditary Angioedema Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pharming Group NV Hereditary Angioedema Drug Production Growth Rate (2014-2019)
Table Pharming Group NV Hereditary Angioedema Drug Production Market Share (2014-2019)
Figure Pharming Group NV Hereditary Angioedema Drug Revenue Market Share (2014-2019)
Table Pharming Group NV Hereditary Angioedema Drug Main Business and Markets Served
Table Shire plc Hereditary Angioedema Drug Production Sites and Area Served
Table Shire plc Hereditary Angioedema Drug Product Introduction, Application and Specification
Table Shire plc Hereditary Angioedema Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Shire plc Hereditary Angioedema Drug Production Growth Rate (2014-2019)
Table Shire plc Hereditary Angioedema Drug Production Market Share (2014-2019)
Figure Shire plc Hereditary Angioedema Drug Revenue Market Share (2014-2019)
Table Shire plc Hereditary Angioedema Drug Main Business and Markets Served
Table CSL Limited Hereditary Angioedema Drug Production Sites and Area Served
Table CSL Limited Hereditary Angioedema Drug Product Introduction, Application and Specification
Table CSL Limited Hereditary Angioedema Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table CSL Limited Hereditary Angioedema Drug Production Growth Rate (2014-2019)
Table CSL Limited Hereditary Angioedema Drug Production Market Share (2014-2019)
Figure CSL Limited Hereditary Angioedema Drug Revenue Market Share (2014-2019)
Table CSL Limited Hereditary Angioedema Drug Main Business and Markets Served
Table IBio Inc. Hereditary Angioedema Drug Production Sites and Area Served
Table IBio Inc. Hereditary Angioedema Drug Product Introduction, Application and Specification
Table IBio Inc. Hereditary Angioedema Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table IBio Inc. Hereditary Angioedema Drug Production Growth Rate (2014-2019)
Table IBio Inc. Hereditary Angioedema Drug Production Market Share (2014-2019)
Figure IBio Inc. Hereditary Angioedema Drug Revenue Market Share (2014-2019)
Table IBio Inc. Hereditary Angioedema Drug Main Business and Markets Served
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Sites and Area Served
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Introduction, Application and Specification
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Growth Rate (2014-2019)
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Market Share (2014-2019)
Figure BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Market Share (2014-2019)
Table BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Main Business and Markets Served
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Sites and Area Served
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Introduction, Application and Specification
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Growth Rate (2014-2019)
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Production Market Share (2014-2019)
Figure Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Revenue Market Share (2014-2019)
Table Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Main Business and Markets Served
Figure Global Hereditary Angioedema Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Hereditary Angioedema Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Hereditary Angioedema Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Hereditary Angioedema Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Hereditary Angioedema Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Hereditary Angioedema Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Hereditary Angioedema Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Hereditary Angioedema Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Hereditary Angioedema Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Hereditary Angioedema Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Hereditary Angioedema Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Hereditary Angioedema Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Hereditary Angioedema Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Hereditary Angioedema Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Hereditary Angioedema Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Hereditary Angioedema Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Hereditary Angioedema Drug by Application (2019-2025)
Table Hereditary Angioedema Drug Distributors List
Table Hereditary Angioedema Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Pharming Group NV、Shire plc、CSL Limited、IBio Inc.、BioCryst Pharmaceuticals, Inc.、Ionis Pharmaceuticals, Inc.、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の遺伝性血管浮腫薬市場(Global Hereditary Angioedema Drug Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp